Has Christopher Reist received payments from drug or device companies?

Yes. Drug and device makers reported $12,053 in general payments to Christopher Reist across 15 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Christopher Reist did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Christopher Reist come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Christopher Reist

Psychiatry · Long Beach, CANPI 1114972551

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $7,381 of the $12,053 with a category attached, or 61.2%. 7 manufacturers reported payments, led by H. Lundbeck A S at 37.1% of the total. Reporting peaked in 2019 at $7,507 and has fallen 99.5% since, to $35 in 2025. Among psychiatry clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$12,053in general payments, 2019–2025

Across 15 payments — averaging $803.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

H. Lundbeck A S$4K
Boehringer Ingelheim International GmbH$4K
Otsuka Pharmaceutical Development & Commercialization, Inc.$3K
Sunovion Pharmaceuticals Inc.$83
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$35
Lundbeck LLC$28
plus $24 from 1 others

$2,901,109in research payments, 2019–2025

Across 136 payments — averaging $21,332 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Boehringer Ingelheim International GmbH$2.6M
Alkermes, Inc.$117K
Avanir Pharmaceuticals, Inc.$68K
Boehringer Ingelheim$49K
Teva Pharmaceuticals USA, Inc.$48K
AbbVie$15K
plus $2K from 1 others

What the payments were for

Consulting fees$3,00025%
Speaking & faculty fees$7,38161%
Travel & lodging$1,17910%
Food & beverage$4944%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
H. Lundbeck A S	4	$4,474
Boehringer Ingelheim International GmbH	1	$4,231
Otsuka Pharmaceutical Development & Commercialization, Inc.	6	$3,179
Sunovion Pharmaceuticals Inc.	1	$83
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	1	$35
Lundbeck LLC	1	$28
Avanir Pharmaceuticals, Inc.	1	$24

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

REXULTI$4,474

How this compares

$12,053 in reported general payments places this provider in the 95th percentile of 4,954 psychiatry providers in California.

See all psychiatry providers in California →

Other psychiatry in Long Beach

Gustavo AlvaOrange$5.8M
John KooSan Francisco$3M
Jason KelloggIrvine$2.7M
Jonathan MeyerSan Diego$2.3M
Charles Tuan-Tu NguyenIrvine$2.1M
Manoj WaikarLos Gatos$1.9M
Gerald MaguireSan Juan Capistraco$1.8M
Salima BrillmanSunnyvale$1.4M
Bibi DasStanford$1.4M
Konstantinos TripodisBurbank$1M

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →